Clinical trial

Interest of SmartGuard Technology (Predictive System for Stopping Insulin Before Hypoglycemia) in Children With Type 1 Diabetes Treated With Insulin Pump

NCT03882463

Study summary

ClinicalTrials.gov

Interest of SmartGuard Technology (Predictive System for Stopping Insulin Before Hypoglycemia) in Children With Type 1 Diabetes Treated With Insulin Pump

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Continuous glucose monitoring with the stop insulin pump function Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-04-30

PhaseNA

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

Continuous glucose monitoring with the stop insulin pump functionDEVICE

Sponsors & collaborators

CHU de Reimslead sponsor

Mapped research locations

ReimsFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03882463 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.